There is no specific treatment for COVID-19 at present. However, patients with COVID-19 can receive supportive care to help relieve symptoms accordingly, which can effectively improve their condition. In China based on the previous studies, α interferon nebulization can be used in the early stage of the disease. Lopinavir and Ritonavir can also be chosen. A few adaptive randomized placebocontrolled clinical trials have been conducted to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adult patients diagnosed with COVID-19.
The 2019-nCoV is a newly discovered virus, and there are currently no vaccinations against infection. Scientists at home and abroad have started to research and develop vaccine and made significant progress. But just as the development of new drugs will take a long time, a kind of new vaccines is also difficult to come out in the short term. Because of the absence of effective vaccines, active isolation and cut-off transmission are still one of the most effective measures against COVID-19 epidemic.